HUMAN C- REACTIVE PROTEIN (CRP)

THE LATEST IN HUMAN C-REACTIVE PROTEIN (CRP) Research:
Transgenic expression of human C-Reactive Protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury.These in vivo observations support the hypothesis that CRP modulates NO metabolism and may have implications regarding the mechanisms by which CRP modulates vascular disease.Source: Am J Physiol Heart Circ Physiol 293: H489-H495, 2007

human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis.CRP also enhanced myeloma cell secretion of IL-6 and synergized with IL-6 to protect myeloma cells from chemotherapy drug-induced apoptosis. Thus, our results implicate CRP as a potential target for cancer treatment.Source: Cancer Cell, Vol 12, 252-265, 11 September 2007